Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN FOR EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2026
Regulatory Filings Classification · 90% confidence The document is a standardized HKEX monthly return (Form FF301) detailing movements in authorized/issued share capital, share options, convertibles, and confirmations under the Exchange Listing Rules. It is a regulatory compliance filing rather than a financial report, presentation, or announcement of a specific transaction. It does not constitute an annual report, earnings release, M&A filing, or other specialized category. Therefore it falls under general regulatory filings.
2026-06-02 English
MONTHLY RETURN FOR EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return report for Sinopharm Tech Holdings Limited, submitted to the Hong Kong Exchanges and Clearing Limited. It contains comprehensive data on movements in authorised and issued share capital, share options, convertible preference shares, confirmations of compliance with listing rules, and other share capital related information. The document is structured as a regulatory return concerning share capital changes and public float sufficiency, typical of filings required by stock exchanges to monitor capital structure and compliance. It is not an announcement of a report, nor a financial report like an annual or interim report. It is not a proxy, voting result, or management change announcement. The content aligns with a Share Issue/Capital Change filing, as it details share capital movements, share options, and convertible securities.
2026-05-05 English
MONTHLY RETURN FOR EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2026
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report concerning movements in securities, including authorized and issued share capital, share options, convertibles, and confirmations related to compliance with listing rules on The Stock Exchange of Hong Kong Limited. It includes detailed tables of share capital changes, share options, convertible preference shares, and confirmations by an executive director. The document is regulatory in nature, reporting on share capital and securities movements for a specific month (March 2026). It is not an announcement of a report, nor a full financial report like an annual or interim report. It is a regulatory filing required by the exchange to disclose share capital movements and related confirmations. Therefore, it fits best under Regulatory Filings (RNS).
2026-04-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2026
Regulatory Filings Classification · 100% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and share options. As it is a recurring regulatory filing detailing changes in capital structure and share issuance, it falls under the 'Regulatory Filings' category.
2026-03-05 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2437 characters) from Sinopharm Tech Holdings Limited regarding the scheduling of a board meeting to approve upcoming interim results. It does not contain the financial results themselves, but rather notifies the market of the date the results will be discussed and published. According to the 'Menu vs Meal' rule, an announcement regarding the timing or publication of a report is classified as a Report Publication Announcement (RPA).
2026-02-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2026
Share Issue/Capital Change Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Exchanges and Clearing Limited. This is a standard regulatory filing required by the HKEX for listed companies to report monthly movements in securities, share capital, and public float status. It does not represent a specific corporate event like an earnings release, dividend announcement, or M&A activity, but rather a recurring regulatory disclosure of share capital changes. Therefore, it falls under the 'Regulatory Filings' category.
2026-02-05 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.